Replimune Group, Inc. current report, 04 September 2019

Business Context and Reporting Period

Replimune Group, Inc. filed this Form 8-K regarding its 2019 Annual Meeting of Stockholders held on September 4, 2019. The company is a Delaware corporation whose common stock trades on Nasdaq under the symbol REPL. It identified itself as an emerging growth company.

Key Financial and Corporate Metrics

This filing does not provide revenue, profitability, cash flow, margin, debt, liquidity, or other operating financial metrics.

  • PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2020.
  • The filing reports no financial guidance or quantified operating outlook.

Material Changes and Governance Actions

Stockholders approved an amendment to the company’s Third Amended and Restated Certificate of Incorporation. The amendment removed the exclusive federal forum clause and made certain changes to the exclusive Delaware forum clause. The Certificate of Amendment was filed with the Delaware Secretary of State on September 9, 2019.

Class I director nominees Philip Astley-Sparke, Kapil Dhingra, and Joseph Slattery were elected to serve until the 2022 Annual Meeting and until their successors are elected and qualified.

DirectorVotes ForVotes WithheldBroker Non-Votes
Philip Astley-Sparke25,886,0303,929,248641,075
Kapil Dhingra26,041,4883,773,790641,075
Joseph Slattery25,960,1513,855,127641,075
  • Certificate amendment: 27,462,303 votes for, 2,346,355 against, and 6,620 abstentions.
  • Auditor ratification: 30,456,153 votes for, 100 against, and 100 abstentions.

Outlook, Risks, and Unusual Items

The filing contains no management guidance, business outlook, contingencies, or unusual financial items. The forum-selection amendment may affect where certain stockholder litigation can be brought; investors should review the full Certificate of Amendment for its precise legal terms.

Important Facts to Verify

  • Review the filed Certificate of Amendment, Exhibit 3.1, for the exact changes to the federal and Delaware forum provisions.
  • Confirm the effective date and legal effect of the amendment, which was filed on September 9, 2019 following stockholder approval on September 4.
  • Review subsequent filings for any changes in board composition, auditor status, litigation, or financial condition.
  • Note that the report was signed on September 10, 2019, while the reported annual meeting occurred on September 4, 2019.